Kymera Therapeutics Inc (KYMR) financials · rev $39.2M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Kymera Therapeutics Inc (KYMR) rev $39.2M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $39.2M | $47.1M |
| Cost of Revenue | $39.2M | $47.1M |
| Gross Profit | N/A | N/A |
| Operating Income | -$349.4M | -$261.6M |
| Net Income | -$311.4M | -$223.9M |
| EPS (Diluted) | -$3.69 | -$2.98 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $1.74B | $978.0M |
| Current Assets | $871.2M | $510.3M |
| Cash & Equivalents | $357.0M | $120.3M |
| PP&E | $43.2M | $50.5M |
| Total Liabilities | $163.1M | $142.4M |
| Current Liabilities | $83.2M | $67.8M |
| Shareholders' Equity | $1.58B | $835.6M |
| Retained Earnings | -$1.07B | -$754.6M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$232.9M | -$194.5M |
| CapEx | $1.45M | $12.8M |
| Investing Cash Flow | -$521.1M | -$404.1M |
| Financing Cash Flow | $990.7M | $608.9M |
| Net Change in Cash | $236.8M | $10.3M |
| Free Cash Flow | -$234.3M | -$207.3M |
FAQ
What is KYMR P/E and revenue?
Kymera Therapeutics Inc (KYMR) rev $39.2M.
What is KYMR revenue?
Kymera Therapeutics Inc last cached revenue is $39.2M (FY2025).
Is KYMR profitable?
Kymera Therapeutics Inc last cached net income is -$311.4M (FY2025).
What are KYMR total assets?
Kymera Therapeutics Inc last cached total assets are $1.74B (FY2025).
What is KYMR free cash flow?
Kymera Therapeutics Inc last cached free cash flow is -$234.3M (FY2025).
Not investment advice. Cached statements, not a live tape.